{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:24:42Z","timestamp":1794576282551,"version":"4.9.1"},"reference-count":88,"publisher":"Informa UK Limited","issue":"14-15","license":[{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Bioanalysis"],"published-print":{"date-parts":[[2026,10,13]]},"DOI":"10.1080\/17576180.2026.2744071","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:40:41Z","timestamp":1791978041000},"page":"1303-1316","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Applications of enzyme activity assays in clinical development for rare disease therapeutics"],"prefix":"10.1080","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1434-654X","authenticated-orcid":false,"given":"Catherine","family":"Vrentas","sequence":"first","affiliation":[{"name":"Boston Biomarkers","place":["Cambridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3113-5800","authenticated-orcid":false,"given":"Karen J.","family":"Quadrini","sequence":"additional","affiliation":[{"name":"Prothena Biosciences Inc","place":["Brisbane, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7498-9197","authenticated-orcid":false,"given":"Yan G.","family":"Ni","sequence":"additional","affiliation":[{"name":"Passage Bio","place":["Philadelphia, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-023-00821-6"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79104-5"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101453"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2024.101318"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12269"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-024-00966-y"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2021.12.013"},{"key":"e_1_3_6_10_1","unstructured":"Piccoli SP Sauer JM. Points to consider document: scientific and regulatory considerations for the analytical validation of assays used in the qualification of biomarkers in biological matrices [Internet]. 2019 [cited 2026 Sep 20]. Available from: https:\/\/media.c-path.org\/wp-content\/uploads\/20240427170322\/EvidConsid-WhitePaper-AnalyticalSectionV20190621-1.pdf"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/17576180.2024.2376436"},{"key":"e_1_3_6_12_1","unstructured":"U.S. Food and Drug Administration (FDA). Biomarker qualification: evidentiary framework [Internet]. 2018 [cited 2026 Sep 20]. Available from: https:\/\/www.fda.gov\/media\/122319\/download"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.13600"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2020.11.028"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/26330040251405830"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12080"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-025-03705-4"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.70166"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1712649"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0036-1"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.5582\/irdr.2020.01011"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2025.05.010"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.2147\/HMER.S201630"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.20114"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105233242104"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2005.tb02116.x"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2022.102231"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/s10038-019-0662-9"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2014.952627"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(00)00139-3"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1516026"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2508681"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(17)30087-1"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0012-9"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2025.04.045"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-024-00674-1"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells14151147"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000002611"},{"key":"e_1_3_6_39_1","unstructured":"Health Resources & Service Administration Federal Advisory Committees. Recommended uniform screening panel [Internet]. 2024 [cited 2026 Sep 20]. Available from: https:\/\/www.hrsa.gov\/advisory-committees\/heritable-disorders\/rusp#:~:text=The%20RUSP%20is%20a%20list the%20Public%20Health%20Service%20Act"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2026.110114"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-025-03979-8"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10050294"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2021.03.016"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmd2.12117"},{"key":"e_1_3_6_45_1","unstructured":"CLSI (Clinical and Laboratory Standards Institute). EP28-A3c: defining establishing and verifying reference intervals in the clinical laboratory [Internet]. 2010 [cited 2026 Sep 20]. Available from: https:\/\/clsi.org\/shop\/standards\/ep28\/"},{"issue":"1","key":"e_1_3_6_46_1","first-page":"S93","article-title":"Reference intervals","volume":"29","author":"Jones G","year":"2008","unstructured":"Jones G, Barker A. Reference intervals. Clin Biochem Rev. 2008;29(Suppl 1):S93\u2013S97.","journal-title":"Clin Biochem Rev"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2018-0059"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1055\/a-1845-2335"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1177\/0009922811410309"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.51507"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2025.109138"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2023.107698"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2024.108612"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijns10010010"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-005-9045-3"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-025-01135-5"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio-2023-0110"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.70377"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-025-01176-w"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio-2017-0284"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e318133fb1b"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-018-0721-y"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1484"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2009.08.003"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-022-01219-4"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2011.07.020"},{"key":"e_1_3_6_67_1","unstructured":"U.S. Food and Drug Administration (FDA). Clinical review addendum (for velaglucerase alfa) [Internet]. 2010 [cited 2026 Sep 20] Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2010\/022575s000medr.pdf"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2018.09.003"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-008-9048-1"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/8904_2017_34"},{"key":"e_1_3_6_71_1","unstructured":"U. S. Food and Drug Administration (FDA). Immunogenicity testing of therapeutic protein products \u2014 developing and validating assays for anti-drug antibody detection guidance for industry [Internet]. 2019 [cited 2026 Sep 20]. Available from: https:\/\/www.fda.gov\/media\/119788\/download"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02017-1"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30374-9"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1233158"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1093\/jalm\/jfaa108"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2405727"},{"key":"e_1_3_6_77_1","unstructured":"U.S. Food and Drug Administration (FDA). Lenmeldy [Internet]. 2025 [cited 2026 Sep 20]. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/cellular-gene-therapy-products\/lenmeldy"},{"key":"e_1_3_6_78_1","unstructured":"Chou W Forman M Al-Zaidy S. PBGM01 study in infantile GM1 Gangliosidosis [Press Release] [Internet]. 2023 [cited 2026 Sep 20]. Available from: https:\/\/s203.q4cdn.com\/877117837\/files\/doc_events\/2023\/Aug\/07\/gm1-c4-data-presentation-deck-final-8723.pdf"},{"key":"e_1_3_6_79_1","unstructured":"Vivet Therapeutics. Vivet Therapeutics presents interim data on its phase 1\/2 gateway trial for the treatment of Wilson disease at EASL Congress 2024 [Press Release] [Internet]. 2024 [cited 2026 Sep 20]. Available from: https:\/\/www.vivet-therapeutics.com\/vivet-therapeutics-presents-interim-data-on-its-phase-1-2-gateway-trial-for-the-treatment-of-wilson-disease-at-easl-congress-2024\/"},{"key":"e_1_3_6_80_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio-2019-0008"},{"key":"e_1_3_6_81_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.12.164"},{"key":"e_1_3_6_82_1","unstructured":"U.S. Food and Drug Administration. Bioanalytical method validation for biomarkers guidance for industry [Internet]. 2026 [cited 2026 Sep 20]. Available from: https:\/\/www.fda.gov\/media\/185276\/download"},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.1080\/17576180.2026.2624362"},{"key":"e_1_3_6_84_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-012110-142317"},{"key":"e_1_3_6_85_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12316"},{"key":"e_1_3_6_86_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020370"},{"key":"e_1_3_6_87_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2020-1521"},{"key":"e_1_3_6_88_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-025-01033-w"},{"key":"e_1_3_6_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-4165(89)90097-4"},{"key":"e_1_3_6_90_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio-2022-0081"}],"container-title":["Bioanalysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17576180.2026.2744071","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/17576180.2026.2744071","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17576180.2026.2744071","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:51:23Z","timestamp":1794574283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17576180.2026.2744071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":88,"journal-issue":{"issue":"14-15","published-print":{"date-parts":[[2026,10,13]]}},"alternative-id":["10.1080\/17576180.2026.2744071"],"URL":"https:\/\/doi.org\/10.1080\/17576180.2026.2744071","relation":{},"ISSN":["1757-6180","1757-6199"],"issn-type":[{"value":"1757-6180","type":"print"},{"value":"1757-6199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-02-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}